Description
BSE announces the upcoming listing and admission to trading of equity shares of Gujarat Kidney and Super Speciality Limited with scrip code 544666 and symbol GKSL.
Summary
BSE has informed trading members that equity shares of Gujarat Kidney and Super Speciality Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544666, symbol GKSL, and ISIN number INE0V0W01025. The specific listing date and detailed security information will be communicated through a separate notice.
Key Points
- Company Name: Gujarat Kidney and Super Speciality Limited
- Scrip Code: 544666
- Trading Symbol: GKSL
- ISIN Number: INE0V0W01025
- Listing status: Approved, pending specific date announcement
- Separate notice will provide exact listing date and security details
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members should:
- Note the scrip code (544666) and symbol (GKSL) for Gujarat Kidney and Super Speciality Limited
- Await separate notice for the actual listing date and security details before commencing trading
- Ensure systems are updated with the new listing information
Important Dates
- Notice Date: December 29, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine listing announcement with minimal immediate market impact. The addition of Gujarat Kidney and Super Speciality Limited to BSE’s equity segment expands the exchange’s listed universe in the healthcare/specialty medical services sector. Trading members will need to await the separate notice for the actual commencement date before the security can be traded. No action required until the listing date is formally announced.
Impact Justification
Routine new listing announcement for a single company with no immediate trading date specified; limited market-wide impact